Di Zheng

Shanghai, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications

First-line treatments for KRAS-mutant non-small cell lung cancer: current state and future perspectives.

First-line treatments for KRAS-mutant non-small cell lung cancer: current state and future perspectives.

Journal: Cancer biology & therapy
Published: December 16, 2024

Perioperative Treatment in EGFR-Mutant Early-Stage Non-Small Cell Lung Cancer: Current Evidence and Future Perspectives.

Perioperative Treatment in EGFR-Mutant Early-Stage Non-Small Cell Lung Cancer: Current Evidence and Future Perspectives.

Journal: Thoracic cancer
Published: October 01, 2024

Allelic Context of EGFR C797X-Mutant Lung Cancer Defines Four Subtypes With Heterogeneous Genomic Landscape and Distinct Clinical Outcomes.

Allelic Context of EGFR C797X-Mutant Lung Cancer Defines Four Subtypes With Heterogeneous Genomic Landscape and Distinct Clinical Outcomes.

Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: July 03, 2023

Telehealth With Comprehensive Live-Fed Real-World Data as a Patient Care Platform for Lung Cancer: Implementation and Evaluation Study.

Telehealth With Comprehensive Live-Fed Real-World Data as a Patient Care Platform for Lung Cancer: Implementation and Evaluation Study.

Journal: JMIR cancer
Published: December 28, 2022

Expert consensus on multi-disciplinary treatment, whole-course pulmonary rehabilitation management in patients with lung cancer and chronic obstructive lung disease.

Expert consensus on multi-disciplinary treatment, whole-course pulmonary rehabilitation management in patients with lung cancer and chronic obstructive lung disease.

Journal: Annals of palliative medicine
Published: March 19, 2022

Circulating tumor DNA clearance predicts prognosis across treatment regimen in a large real-world longitudinally monitored advanced non-small cell lung cancer cohort.

Circulating tumor DNA clearance predicts prognosis across treatment regimen in a large real-world longitudinally monitored advanced non-small cell lung cancer cohort.

Journal: Translational lung cancer research
Published: May 19, 2020

The in cis compound EGFR mutations in Chinese advanced non-small cell lung cancer patients.

The in cis compound EGFR mutations in Chinese advanced non-small cell lung cancer patients.

Journal: Cancer biology & therapy
Published: April 17, 2019

EGFR G796D mutation mediates resistance to osimertinib.

EGFR G796D mutation mediates resistance to osimertinib.

Journal: Oncotarget
Published: March 08, 2017

Overexpression of miR-100 inhibits cancer growth, migration, and chemosensitivity in human NSCLC cells through fibroblast growth factor receptor 3.

Overexpression of miR-100 inhibits cancer growth, migration, and chemosensitivity in human NSCLC cells through fibroblast growth factor receptor 3.

Journal: Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine
Published: July 08, 2015

Diagnostic value of circulating free DNA for the detection of EGFR mutation status in NSCLC: a systematic review and meta-analysis.

Diagnostic value of circulating free DNA for the detection of EGFR mutation status in NSCLC: a systematic review and meta-analysis.

Journal: Scientific reports
Published: May 28, 2014

Association between vitamin C intake and lung cancer: a dose-response meta-analysis.

Association between vitamin C intake and lung cancer: a dose-response meta-analysis.

Journal: Scientific reports
Published: April 23, 2014
Showing 1-11 of 11

Last Updated: 09/26/2026